R&D
At More Reyra, we recognize that research and development (R&D) can be the decisive factor between ordinary outcomes and extraordinary success. We operate dedicated R&D units for API and Formulation Development, each of which is approved by DSIR (Department of Scientific and Industrial Research).
Research and Development (R&D) serves as a pivotal growth engine for More Reyra, led by a team of highly qualified scientists and equipped with state-of-the-art facilities. Our ongoing R&D efforts have bolstered our product portfolio, positioning us as a leader in manufacturing niche and complex APIs across Oncology, Immunosuppressant, Antibiotic, and Antifungal segments. Since our inception, More Reyra has introduced numerous groundbreaking products and maintains a robust pipeline. The API R&D team focuses primarily on fermentation, semi-synthesis, and synthesis-based products that adhere to European and US regulatory standards and guidelines.
More Reyra is actively engaged in Contract Research & Manufacturing projects with international companies, specializing in strain improvement, media optimization, and scaling up products from R&D to Pilot and commercial scales—from conceptualization through to commercialization. Our R&D efforts benefit from strong support from an Analytical Development Laboratory. With More Reyra’s manufacturing site meeting global regulatory standards, our customers enjoy the flexibility to pursue global filings for their projects. The Formulation R&D team concentrates on developing specialty generic formulations across Immunology, Oncology, Hematology, Dermatology, Injectable, and Small Volume Parenteral Forms, aiming for global regulatory approvals.
FORMULATION
DEVELOPMENT
API
R&D CHEMICAL
API
R&D BIOTECHNOLOGY
More Reyra has established a world-class Formulation and Analytical Development Laboratory to develop and commercialize complex niche generic formulations for global markets.
More Reyra operates a state-of-the-art R&D facility certified by DSIR (Department of Science & Industrial Research), specializing in the development of advanced biotechnology products
